tirzepatide triple agonist vs. Retatrutide: The Science Behind Dual and Triple-Agonist Metabolic Peptides Retatrutide vs Tirzepatide: Key Differences
Description
GLP-1 medications are priced separately: Wegovy starts at $150/month and Zepbound starts at $275/month, up to 75% less than retail pharmacy prices
Both medications affect gastric motility and liver metabolism, which can alter alcohol tolerance
glucagon component may cause transient heart rate increase
Compared to the first-generation GLP-1R agonist, tirzepatide has three critical improvements: first, many residues in peptide backbone are changed to obtain GIPR-activating activity
Both medications share similar side effect profiles with Tirzepatide showing slightly better tolerability
